Mochida Pharmaceutical Co.,Ltd. [4534.T]

TOKYO, Jun 01 (Pulse News Wire) – Mochida Pharmaceutical Co., Ltd. (4534.T) announced progress on its share repurchase program.

The company acquired 35,300 shares for a total of ¥124,315,000 during the period from May 18, 2026 to May 31, 2026 through open market purchases. The program is 6.7% complete with 35,300 shares acquired to date.

Share buyback

Shares

35,300 shares

Total cost

¥124M

Avg ¥3,522/share

Period

2026-05-18 to 2026-05-31

Progress vs authorization

35,300 shares of 530,000 shares (6.7%)

Source: TDNet filing

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.